IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to save this paper

Biotechnology business in Norway: Peripheral advantage, or just periphery?

Listed author(s):
  • Terje Grønning

    (Department of educational research, University of Oslo)

Research on biotechnology related firms has long been associated with the agglomeration of “dedicated biotechnology firms” and partners such as large corporations, research institutes and venture capital firms. At the same time it is acknowledged that such agglomeration trends may be most closely associated with medical biotechnology. This paper shows that there are more than 130 firms which may be classified as biotechnology related firms in Norway. Furthermore they are spread out throughout the country, albeit with more than half being located in the Eastern part. While there is indeed a great preoccupation with medical biotechnology also in Norway, the survey shows that two other distinct traits are present: a concentration of firms being focused on diagnostics and drug delivery rather than on therapeutics, and a focus on marine biotechnology (more than one third of the firms) within nutrition related products rather than or in addition to medical products. In addition to contributing these descriptive findings the paper thus opens up the agglomeration discussion, and suggests that foci on such niches as those which are prevalent in Norway may function with geographical distribution patterns different from those prevalent within the current medical biotechnology focused literature.

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL:
Download Restriction: no

Paper provided by Centre for Technology, Innovation and Culture, University of Oslo in its series Working Papers on Innovation Studies with number 20070607.

in new window

Length: 42 pages
Date of creation: Aug 2007
Handle: RePEc:tik:inowpp:20070607
Contact details of provider: Postal:
Postboks 1108 Blindern N-0317 Oslo

Phone: 22 84 16 00
Fax: : 22 84 16 01
Web page:

More information through EDIRC

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:

in new window

  1. Susan Bartholomew, 1997. "National Systems of Biotechnology Innovation: Complex Interdependence in the Global System," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 28(2), pages 241-266, June.
  2. Niosi, Jorge, 2003. "Alliances are not enough explaining rapid growth in biotechnology firms," Research Policy, Elsevier, vol. 32(5), pages 737-750, May.
  3. Gunnar Eliasson, 2000. "Industrial policy, competence blocs and the role of science in economic development," Journal of Evolutionary Economics, Springer, vol. 10(1), pages 217-241.
  4. Goldfarb, Brent & Henrekson, Magnus & Rosenberg, Nathan, 2001. "Demand vs. Supply Driven Innovations: US and Swedish Experiences in Academic Entrepreneurship," SSE/EFI Working Paper Series in Economics and Finance 0436, Stockholm School of Economics.
  5. Günseli Baygan, 2003. "Venture Capital Policy Review: Norway," OECD Science, Technology and Industry Working Papers 2003/17, OECD Publishing.
Full references (including those not matched with items on IDEAS)

This item is featured on the following reading lists or Wikipedia pages:

  1. Technology Assessment

When requesting a correction, please mention this item's handle: RePEc:tik:inowpp:20070607. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (H&kon Normann)

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.